Yue Wang

发表

Distinguishing lung tumours from normal lung based on a small set of genes.

W. Xiao, J. Jen, Ping Yang, 2007, Lung cancer.

[Effects of p53 antisense RNA on malignant phenotype and sensitivity to cisplatin of human lung cancer cell line].

Hui Wang, Yue Wang, B. Lai, 2002, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

mTOR and PTEN expression in non-small cell lung cancer: analysis by real-time fluorescence quantitative polymerase chain reaction and immunohistochemistry

Shaofa Xu, Yue Wang, W. Yue, 2012, Surgery Today.

Overexpression of cyclin Y in non-small cell lung cancer is associated with cancer cell proliferation

Zhidong Liu, Shaofa Xu, Yue Wang, 2010, Science China Life Sciences.

Polymorphisms in GSTM1, CYP1A1, CYP2E1, and CYP2D6 are Associated with Susceptibility and Chemotherapy Response in Non-small-cell Lung Cancer Patients

Yue Wang, Xue-hui Yang, Chunyan Zhang, 2012, Lung.

Cyclooxygenase-2 is associated with malignant phenotypes in human lung cancer

Hui Wang, Yue Wang, B. Lai, 2016, Oncology letters.

COX-2 silencing inhibits cell proliferation in A549 cell

Yue Wang, Xue-hui Yang, Chunyan Zhang, 2011 .

CAR‐T cell therapy for lung cancer: Potential and perspective

Yue Wang, Yu-jie Lei, Yunchao Huang, 2022, Thoracic cancer.

Downregulation of PAX6 by shRNA Inhibits Proliferation and Cell Cycle Progression of Human Non-Small Cell Lung Cancer Cell Lines

Yue Wang, Chunyan Zhang, Wenyun Jia, 2014, PloS one.

Knock-down of microRNA miR-556-5p increases cisplatin-sensitivity in non-small cell lung cancer (NSCLC) via activating NLR family pyrin domain containing 3 (NLRP3)-mediated pyroptotic cell death

Yue Wang, Feng Shi, Xing Liu, 2021, Bioengineered.

Cell cycle protein cyclin Y is associated with human non-small-cell lung cancer proliferation and tumorigenesis.

Zhidong Liu, Shaofa Xu, Yue Wang, 2011, Clinical lung cancer.

A plasma miRNA signature for lung cancer early detection

M. Zhan, Yue Wang, F. Jiang, 2017, Oncotarget.

Comparison between NOD/SCID mice and BALB/c mice for patient-derived tumor xenografts model of non-small-cell lung cancer

Yue Wang, M. Jiang, Yaodong Miao, 2018, Cancer management and research.

A Direct Plasma miRNA Assay for Early Detection and Histological Classification of Lung Cancer

Yue Wang, F. Jiang, Q. Leng, 2018, Translational oncology.

Expression and clinical significance of mTOR in surgically resected non-small cell lung cancer tissues: a case control study.

Yue Wang, W. Yue, Zhe Liu, 2012, Asian Pacific journal of cancer prevention : APJCP.

Serological investigation of the clinical significance of fascin in non-small-cell lung cancer.

Shaofa Xu, Yue Wang, Chunyan Zhang, 2013, Lung cancer.

ABCC4 is required for cell proliferation and tumorigenesis in non-small cell lung cancer

Yue Wang, W. Yue, Lina Zhang, 2014, OncoTargets and therapy.

ABCC4 is required for cell proliferation and tumorigenesis in non-small cell lung cancer

Yue Wang, W. Yue, Lina Zhang, 2014, OncoTargets and therapy.

Construction and quality identification of T7 recombination expression cDNA library form human lung cancer

Yue Wang, W. Yue, Lina Zhang, 2009 .

[Construction of a t7 human lung cancer cDNA library.].

Yue Wang, W. Yue, Lina Zhang, 2008, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

[Screening and Identification of Non-Small-Cell Lung Cancer Associated Antigen with SEREX.].

Ying Sun, Yue Wang, W. Yue, 2009, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Downregulation of Cyclophilin A by siRNA diminishes non-small cell lung cancer cell growth and metastasis via the regulation of matrix metallopeptidase 9

Yue Wang, Chunyan Zhang, Wenyun Jia, 2012, BMC Cancer.

[The Relationship between the PI3K/Akt/mTOR Signal Transduction Pathway and Non-small Cell Lung Cancer.].

Yue Wang, W. Yue, Xiaoming Wang, 2009, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Serum Anti-CCNY Autoantibody Is an Independent Prognosis Indicator for Postoperative Patients with Early-Stage Nonsmall-Cell Lung Carcinoma

Yue Wang, W. Yue, Lina Zhang, 2013, Disease markers.

[Detecting EGFR autoantibodies in serums of NSCLC patients with peptide array].

Shaofa Xu, Yue Wang, W. Yue, 2010, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

PIK3CA gene mutation associated with poor prognosis of lung adenocarcinoma

Yue Wang, W. Yue, Lei Shi, 2013, OncoTargets and therapy.

Prognostic significance of circulating laminin gamma2 for early-stage non-small-cell lung cancer

Yue Wang, W. Yue, Lina Zhang, 2016, OncoTargets and therapy.

Preliminary results of a randomized phase II trial of pemetrexed (P) + carboplatin (Cb) ± enzastaurin (ENZ) versus docetaxel (D) + Cb as first-line treatment of patients with stage IIIB/IV non-small cell lung cancer (NSCLC)

C. Obasaju, M. Socinski, T. Stinchcombe, 2008 .

The role of ZFX in non-small cell lung cancer development.

Mei Jiang, Xiaoting Zhao, Wentao Yue, 2012, Oncology research.

Targeting growth hormone in cancer: future perspectives.

Yue Wang, J. Perry, S. Jamieson, 2023, Endocrine-Related Cancer.

Loss of EGFR confers acquired resistance to AZD9291 in an EGFR-mutant non-small cell lung cancer cell line with an epithelial–mesenchymal transition phenotype

Jing Xu, Yu Teng, Mei Jiang, 2018, Journal of Cancer Research and Clinical Oncology.

[Effects of p53 gene on drug resistance in human lung cancer cell lines.].

Hui Wang, Yue Wang, B. Lai, 2008, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

非小细胞肺癌患者中Survivin抗体的临床意义及诊断价值

Yue Wang, Xue-hui Yang, Chunyan Zhang, 2010, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Ⅰ、Ⅱ相药物代谢酶遗传多态性与晚期非小细胞肺癌化疗疗效的关系

Yue Wang, Xue-hui Yang, Chunyan Zhang, 2011, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Oncotargets and Therapy Dovepress Prognostic Significance of Circulating Laminin Gamma2 for Early-stage Non-small-cell Lung Cancer

Yue Wang, W. Yue, Lina Zhang, 2022 .